BRPI0918844A2 - syngr4 para genes-alvo de terapia e diagnóstico do câncer - Google Patents
syngr4 para genes-alvo de terapia e diagnóstico do câncerInfo
- Publication number
- BRPI0918844A2 BRPI0918844A2 BRPI0918844A BRPI0918844A BRPI0918844A2 BR PI0918844 A2 BRPI0918844 A2 BR PI0918844A2 BR PI0918844 A BRPI0918844 A BR PI0918844A BR PI0918844 A BRPI0918844 A BR PI0918844A BR PI0918844 A2 BRPI0918844 A2 BR PI0918844A2
- Authority
- BR
- Brazil
- Prior art keywords
- syngr4
- target genes
- cancer diagnosis
- therapy target
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19035808P | 2008-08-27 | 2008-08-27 | |
| PCT/JP2009/004059 WO2010023866A1 (en) | 2008-08-27 | 2009-08-24 | Syngr4 for target genes of cancer therapy and diagnosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0918844A2 true BRPI0918844A2 (pt) | 2015-12-08 |
Family
ID=41721049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0918844A BRPI0918844A2 (pt) | 2008-08-27 | 2009-08-24 | syngr4 para genes-alvo de terapia e diagnóstico do câncer |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20110262463A1 (pt) |
| EP (1) | EP2350276A4 (pt) |
| JP (1) | JP2012501161A (pt) |
| KR (1) | KR20110063490A (pt) |
| CN (1) | CN102203250A (pt) |
| BR (1) | BRPI0918844A2 (pt) |
| CA (1) | CA2734979A1 (pt) |
| RU (1) | RU2011111387A (pt) |
| WO (1) | WO2010023866A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105264381B (zh) * | 2013-05-16 | 2018-06-01 | 国立大学法人京都大学 | 用于确定癌症预后的方法 |
| CN103913570B (zh) * | 2014-03-24 | 2016-03-23 | 张灏 | 癌症危险分层生物标志物、其应用以及癌症危险分层装置 |
| CN112626118B (zh) * | 2020-11-12 | 2023-06-23 | 清华-伯克利深圳学院筹备办公室 | 细胞株及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4679149B2 (ja) * | 2002-09-30 | 2011-04-27 | オンコセラピー・サイエンス株式会社 | ヒト膵癌に関連する遺伝子およびポリペプチド |
| AU2002344094A1 (en) * | 2002-10-16 | 2004-05-04 | Ngk Insulators, Ltd. | Human housekeeping genes and human tissue-specific genes |
| US7700573B2 (en) * | 2004-03-23 | 2010-04-20 | Oncotherapy Science, Inc. | Method for diagnosing non-small lung cancer |
| EP2061900A2 (en) * | 2006-08-25 | 2009-05-27 | Oncotherapy Science, Inc. | Prognostic markers and therapeutic targets for lung cancer |
-
2009
- 2009-08-24 BR BRPI0918844A patent/BRPI0918844A2/pt not_active Application Discontinuation
- 2009-08-24 JP JP2011509326A patent/JP2012501161A/ja active Pending
- 2009-08-24 RU RU2011111387/10A patent/RU2011111387A/ru unknown
- 2009-08-24 CA CA2734979A patent/CA2734979A1/en not_active Abandoned
- 2009-08-24 CN CN2009801427497A patent/CN102203250A/zh active Pending
- 2009-08-24 US US13/060,677 patent/US20110262463A1/en not_active Abandoned
- 2009-08-24 KR KR1020117006972A patent/KR20110063490A/ko not_active Withdrawn
- 2009-08-24 EP EP09809522A patent/EP2350276A4/en not_active Withdrawn
- 2009-08-24 WO PCT/JP2009/004059 patent/WO2010023866A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2350276A1 (en) | 2011-08-03 |
| CA2734979A1 (en) | 2010-03-04 |
| KR20110063490A (ko) | 2011-06-10 |
| WO2010023866A1 (en) | 2010-03-04 |
| CN102203250A (zh) | 2011-09-28 |
| EP2350276A4 (en) | 2012-07-25 |
| RU2011111387A (ru) | 2012-10-10 |
| JP2012501161A (ja) | 2012-01-19 |
| US20110262463A1 (en) | 2011-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1008566A2 (pt) | métodos e composições para o diagnóstico e tratamento de câncer | |
| HRP20181385T1 (hr) | Ciljanje abcb5 za terapiju raka | |
| BRPI1015215A2 (pt) | porções de ligação alvo armadas com amatoxina para o tratamento de câncer | |
| BRPI0921321A2 (pt) | métodos para o tratamento de indwcções e tumores | |
| BRPI0924549A2 (pt) | nano fotomedicamentos como alvo para terapia fotodinâmica do câncer | |
| BRPI0821660A2 (pt) | Combinações de agentes terapêuticos para tratamento de câncer | |
| BRPI0906389A2 (pt) | Sistema de terapia de pele | |
| BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
| EP2373794A4 (en) | NECTIN-4 FOR TARGET GENES TO CANCER THERAPY AND DIAGNOSIS | |
| BR112012005594A2 (pt) | tratamento de câncer | |
| BRPI0919238A2 (pt) | métodos e composições para o tratamento de câncer | |
| BRPI0821779A2 (pt) | tratamento terapêutico de câncer | |
| BRPI0821248A2 (pt) | Inibidores de cinesina como fármacos terapêuticos para câncer | |
| PL2535716T3 (pl) | Marker nowotworowy i cel terapeutyczny | |
| BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
| BRPI1010874A2 (pt) | composição para o tratamento de câncer de próstata | |
| BR112012002797A2 (pt) | tratamento de câncer de próstata | |
| BRPI0922884A2 (pt) | compostos para tratamento de câncer | |
| DK2219683T3 (da) | Målrettet radioterapi | |
| IL240560A0 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| EP2432539A4 (en) | Hyperthermia assisted radiation therapy | |
| BRPI1007995A2 (pt) | orto-aminoamidas para o tratamento de cãncer. | |
| BRPI0909016A2 (pt) | anticorpos úteis para o tratamento do câncer | |
| BRPI0813364A2 (pt) | Métodos de diagnóstico e tratamento de câncer. | |
| BRPI0920743A2 (pt) | ribonucleases terapeuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |